Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer

Affiliations

• ¹ Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
• ² Clinical Cooperation Unit "Applied Tumor Immunity", German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ³ Computational Oncology Group, Molecular Precision Oncology Program, NCT and DKFZ, Heidelberg, Germany.
• ⁴ Division of Gynecological Oncology, NCT, University Hospital Heidelberg, Heidelberg, Germany.
• ⁵ Division of Molecular Genetics, DKFZ, Heidelberg, Germany.
• ⁶ NCT Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany.
• ⁷ German Cancer Consortium (DKTK), Heidelberg, Germany.
• ⁸ Institute for Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• ⁹ Department of Diagnostics and Interventional Radiology, Thoraxklinik Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.
• ¹⁰ DNA Vector Lab, DKFZ, Heidelberg, Germany.
• ¹¹ GMP and T Cell Therapy Group, DKFZ, Heidelberg, Germany.